Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Suzanne Fiorillo

Concepts (116)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Kaposi
6
2025
75
0.890
Why?
HIV Infections
10
2024
2696
0.620
Why?
HIV Seropositivity
2
2021
118
0.550
Why?
Q Fever
1
2013
5
0.430
Why?
Mycoses
1
2013
70
0.410
Why?
Herpesvirus 8, Human
5
2021
61
0.410
Why?
Radiography, Thoracic
1
2013
162
0.400
Why?
Pneumococcal Infections
1
2013
110
0.390
Why?
Fever
1
2013
301
0.380
Why?
Sexual Behavior
3
2018
453
0.380
Why?
Counseling
1
2012
382
0.310
Why?
Anti-Retroviral Agents
3
2024
229
0.300
Why?
AIDS-Related Opportunistic Infections
2
2021
124
0.280
Why?
Macrophages, Alveolar
2
2020
389
0.260
Why?
alpha 1-Antichymotrypsin
1
2025
4
0.240
Why?
Mass Screening
1
2012
1121
0.230
Why?
Gastrointestinal Microbiome
2
2024
635
0.220
Why?
Anti-HIV Agents
3
2017
743
0.210
Why?
Zimbabwe
6
2024
54
0.210
Why?
Tanzania
2
2013
42
0.200
Why?
Bronchoalveolar Lavage Fluid
2
2021
642
0.190
Why?
Lung Neoplasms
2
2025
2353
0.170
Why?
Hexosaminidases
1
2019
18
0.160
Why?
Prevotella
1
2018
14
0.160
Why?
T-Lymphocytes, Regulatory
1
2021
377
0.150
Why?
Biomarkers, Tumor
1
2025
1170
0.150
Why?
Anti-Inflammatory Agents
1
2020
468
0.140
Why?
Sexual and Gender Minorities
1
2018
157
0.130
Why?
Up-Regulation
1
2019
848
0.120
Why?
Insulin-Like Growth Factor I
1
2017
308
0.120
Why?
Herpesviridae Infections
2
2021
142
0.120
Why?
International Cooperation
1
2014
172
0.110
Why?
Inflammation
2
2024
2694
0.110
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
18
0.110
Why?
Adipose Tissue
1
2017
588
0.110
Why?
Adult
11
2025
35361
0.110
Why?
Body Composition
1
2017
654
0.100
Why?
HIV-1
5
2021
840
0.100
Why?
Middle Aged
9
2025
30977
0.100
Why?
HIV Seronegativity
1
2012
25
0.100
Why?
DNA, Viral
2
2013
380
0.100
Why?
Vitamin D Deficiency
1
2014
179
0.100
Why?
Universities
1
2014
404
0.100
Why?
Confidentiality
1
2012
70
0.090
Why?
Aged, 80 and over
2
2013
7050
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
985
0.090
Why?
Vitamin D
1
2014
384
0.090
Why?
RNA, Viral
1
2014
622
0.090
Why?
Male
12
2025
63146
0.090
Why?
Sexual Partners
1
2012
179
0.090
Why?
Drug Monitoring
1
2010
193
0.080
Why?
Female
11
2025
68162
0.080
Why?
Risk-Taking
1
2012
344
0.080
Why?
Diagnosis, Differential
1
2013
1435
0.080
Why?
Acquired Immunodeficiency Syndrome
1
2010
226
0.080
Why?
Smokers
2
2020
135
0.080
Why?
Plasma
1
2010
198
0.080
Why?
Incidence
2
2013
2634
0.080
Why?
Humans
16
2025
128896
0.080
Why?
Biomedical Research
1
2014
654
0.070
Why?
Predictive Value of Tests
1
2013
1967
0.070
Why?
Muscle, Skeletal
1
2017
1629
0.070
Why?
Prospective Studies
5
2022
7060
0.070
Why?
Aged
4
2013
22035
0.060
Why?
Lamivudine
2
2017
61
0.060
Why?
Zidovudine
2
2017
78
0.060
Why?
Adolescent
3
2013
20197
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2012
1264
0.050
Why?
Young Adult
3
2019
12286
0.050
Why?
Antiretroviral Therapy, Highly Active
2
2017
267
0.050
Why?
Antigens, Viral
1
2021
181
0.050
Why?
Viral Load
2
2013
448
0.040
Why?
Infant
1
2013
8994
0.040
Why?
Immunophenotyping
1
2020
310
0.040
Why?
Survival Analysis
2
2014
1282
0.040
Why?
Polymerase Chain Reaction
1
2021
1045
0.040
Why?
Child, Preschool
1
2013
10457
0.040
Why?
Proteomics
1
2025
985
0.040
Why?
Early Detection of Cancer
1
2022
349
0.040
Why?
Radiography, Abdominal
1
2017
40
0.030
Why?
Benzoxazines
1
2017
31
0.030
Why?
Pilot Projects
2
2014
1545
0.030
Why?
Case-Control Studies
1
2025
3334
0.030
Why?
Cyclopropanes
1
2017
88
0.030
Why?
Alkynes
1
2017
53
0.030
Why?
Anthropometry
1
2017
205
0.030
Why?
Life Style
1
2018
459
0.030
Why?
Emtricitabine
1
2017
161
0.030
Why?
Drug Combinations
1
2017
327
0.030
Why?
Risk Factors
3
2018
9792
0.030
Why?
CD8-Positive T-Lymphocytes
1
2021
824
0.030
Why?
Tenofovir
1
2017
225
0.030
Why?
CD4-Positive T-Lymphocytes
1
2021
1040
0.030
Why?
Dideoxynucleosides
1
2014
20
0.030
Why?
Organizational Objectives
1
2014
73
0.030
Why?
Accreditation
1
2014
81
0.030
Why?
Organizational Policy
1
2014
76
0.030
Why?
Biomarkers
2
2019
3874
0.030
Why?
Africa South of the Sahara
1
2013
38
0.030
Why?
Child
1
2013
20824
0.030
Why?
Smoking
1
2020
1501
0.030
Why?
United Kingdom
1
2013
263
0.030
Why?
Cytokines
1
2020
1995
0.020
Why?
Longitudinal Studies
1
2018
2668
0.020
Why?
Odds Ratio
1
2014
1019
0.020
Why?
Kaplan-Meier Estimate
1
2013
861
0.020
Why?
Seroepidemiologic Studies
1
2009
155
0.020
Why?
Treatment Outcome
2
2014
10239
0.020
Why?
Curriculum
1
2014
925
0.020
Why?
Tomography, X-Ray Computed
1
2017
2530
0.020
Why?
Lung
1
2020
3925
0.020
Why?
Disease Progression
1
2014
2603
0.020
Why?
Urban Population
1
2009
436
0.020
Why?
Surveys and Questionnaires
1
2018
5355
0.020
Why?
Comorbidity
1
2009
1542
0.010
Why?
United States
1
2014
13975
0.010
Why?
Fiorillo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)